These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 38793033)
1. Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica. Cutolo M; Foppiani L; Minuto F J Endocrinol Invest; 2002; 25(10 Suppl):19-23. PubMed ID: 12508908 [TBL] [Abstract][Full Text] [Related]
2. Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica. van Sleen Y; Graver JC; Abdulahad WH; van der Geest KSM; Boots AMH; Sandovici M; Brouwer E Front Immunol; 2019; 10():1981. PubMed ID: 31507597 [TBL] [Abstract][Full Text] [Related]
3. Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6. Cutolo M; Straub RH; Foppiani L; Prete C; Pulsatelli L; Sulli A; Boiardi L; Macchioni P; Giusti M; Pizzorni C; Seriolo B; Salvarani C J Rheumatol; 2002 Apr; 29(4):748-56. PubMed ID: 11950017 [TBL] [Abstract][Full Text] [Related]
8. Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. GBD 2021 Rheumatoid Arthritis Collaborators Lancet Rheumatol; 2023 Oct; 5(10):e594-e610. PubMed ID: 37795020 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic difficulties in polymyalgia rheumatica cases with normal erythrocyte sedimentation rate and C-reactive protein values. Kara M; Alp G; Koç AM Medicine (Baltimore); 2023 Sep; 102(39):e35385. PubMed ID: 37773830 [TBL] [Abstract][Full Text] [Related]
10. Discovering the deep evolutionary roots of serum amyloid A protein family. Zámocký M; Ferianc P Int J Biol Macromol; 2023 Dec; 252():126537. PubMed ID: 37634776 [TBL] [Abstract][Full Text] [Related]
11. Biomarkers in the era of targeted therapy in giant cell arteritis and polymyalgia rheumatica: is it possible to replace acute-phase reactants? Carvajal Alegria G; Nicolas M; van Sleen Y Front Immunol; 2023; 14():1202160. PubMed ID: 37398679 [TBL] [Abstract][Full Text] [Related]
12. Elderly-onset rheumatoid arthritis vs. polymyalgia rheumatica: Differences in pathogenesis. Wu J; Yang F; Ma X; Lin J; Chen W Front Med (Lausanne); 2022; 9():1083879. PubMed ID: 36714116 [TBL] [Abstract][Full Text] [Related]
13. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Szklarczyk D; Kirsch R; Koutrouli M; Nastou K; Mehryary F; Hachilif R; Gable AL; Fang T; Doncheva NT; Pyysalo S; Bork P; Jensen LJ; von Mering C Nucleic Acids Res; 2023 Jan; 51(D1):D638-D646. PubMed ID: 36370105 [TBL] [Abstract][Full Text] [Related]
14. The roles of extracellular vesicles in the immune system. Buzas EI Nat Rev Immunol; 2023 Apr; 23(4):236-250. PubMed ID: 35927511 [TBL] [Abstract][Full Text] [Related]
15. An update on polymyalgia rheumatica. Lundberg IE; Sharma A; Turesson C; Mohammad AJ J Intern Med; 2022 Nov; 292(5):717-732. PubMed ID: 35612524 [TBL] [Abstract][Full Text] [Related]
16. Immune system activation in polymyalgia rheumatica: Which balance between autoinflammation and autoimmunity? A systematic review. Hysa E; Gotelli E; Sammorì S; Cimmino MA; Paolino S; Pizzorni C; Sulli A; Smith V; Cutolo M Autoimmun Rev; 2022 Feb; 21(2):102995. PubMed ID: 34798314 [TBL] [Abstract][Full Text] [Related]
17. PGLYRP2 as a novel biomarker for the activity and lipid metabolism of systemic lupus erythematosus. Li H; Meng D; Jia J; Wei H Lipids Health Dis; 2021 Aug; 20(1):95. PubMed ID: 34461924 [TBL] [Abstract][Full Text] [Related]